BIIB Related Management Comments

Mar 20, 2013 07:45 AM Biogen Idec (BIIB) PLEGRIDY Met Primary Endpoint in Phase 3 ADVANCE

Mar 4, 2013 07:32 AM Biogen Idec (BIIB) BLA for rFIXFc Accepted by FDA

Jan 9, 2013 09:52 AM Biogen Idex (BIIB) CEO Scangos Says New MS Treatment Will Bolster Offerings

Jan 3, 2013 07:31 AM Biogen Idec (BIIB) Says EMPOWER Missed Primary Endpoint